CD27 and inflammatory bowel disease: When comparing axSpA patients with and without a history of ESM, including uveitis, psoriasis and inflammatory bowel disease (IBD), we observed a significantly higher frequency of CD27-CD38lowCD21low B-cells in patients with a known history of ESM (median=7.05%, P=0.02) compared to patients without ever having an ESM (median=5.9%).